We have returned from the 3rd National HematoOncoGenetic Congress with International Participation, held on 27–29 November 2025 at the Juju Premier Palace Hotel Antalya, with wonderful memories and valuable scientific exchanges.
As the authorized distributor of QIAGEN, it was both an honor and a pleasure for us to attend the congress once again alongside the QIAGEN team. Throughout the three-day event, we closely followed the latest scientific developments and had the opportunity to present our advanced technology solutions to esteemed professors, specialists, and colleagues.
At the congress, QIAGEN’s QIAcuity Digital PCR technologies attracted significant attention thanks to their outstanding performance in precision and accuracy. In addition, the newly introduced Franklin software, added to QIAGEN’s portfolio through a recent partnership, stood out as one of the key innovations showcased this year.
On 28 November, within the scope of the congress, an insightful satellite symposium titled “QIAGEN Digital Insights” was held, moderated by Assoc. Prof. Ahmet Cevdet Ceylan and presented by Ruth Burton from QIAGEN. The session offered a comprehensive overview of clinical applications and highlighted how the Franklin digital data analytics platform contributes to clinical decision-support processes—providing valuable perspectives for both us and all participants.
The strong interest shown in our booth, the fruitful discussions we held, and the new professional connections we established throughout the event brought great motivation and energy to our entire team. We extend our heartfelt appreciation to the Associatıon of Medical Genetics, the organizing committee, all speakers, the QIAGEN family, and our esteemed professors for their contributions to this meaningful gathering.
We look forward to many more scientific meetings together!
